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1. ABSTRACT 
In the last decade the interest in autophagy got an incredible boost and the phenomenon quickly 
turned into an extensive research field. Interestingly, dysfunction of this cytoplasmic clearance 
system has been proposed to lie at the root of multiple diseases including cancer. We therefore 
consider it crucial from a toxicological point of view to investigate if nanomaterials that are 
developed for biomedical applications interfere with this cellular process. Here, we study the highly 
promising ‘gradient alloyed’ quantum dots (QDs) that differ from conventional ones by their  
gradient core composition which allows for better fluorescent properties. We carefully examined the 
toxicity of two identical gradient alloyed QDs, differing only in their surface coatings, namely 3-
mercaptopropionic (MPA) acid and polyethylene glycol (PEG). Next to more conventional 
toxicological endpoints like cytotoxicity and oxidative stress, we examined the influence of these QDs 
on the autophagy pathway. Our study shows that the cellular effects induced by QDs on HeLa cells 
were strongly dictated by the surface coat of the otherwise identical particles. MPA-coated QDs 
proved to be highly biocompatible as a result of lysosomal activation and ROS reduction, two cellular 
responses that help the cell to cope with nanomaterial-induced stress. In contrast, PEGylated QDs 
were significantly more toxic due to increased ROS production and lysosomal impairment. This 
impairment next results in autophagy dysfunction which likely adds to their toxic effects. Taken 
together, our study shows that coating QDs with MPA is a better strategy than PEGylation for long 
term cell tracking with minimal cytotoxicity. 
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2. INTRODUCTION 
Nanotechnology is a rapidly evolving field with a growing potential for a wide range of applications. 
These applications naturally require the design of highly functional though biocompatible 
nanomaterials (NMs). Among the most extensively investigated NMs for biomedical imaging 
applications are Quantum Dots (QDs), which are semiconductor nanocrystals with a size ranging from 
2 to 100 nm.[1] They possess supremely advantageous optical properties including a very high and 
stable fluorescence intensity that is strongly resistant to photobleaching.[2] In addition, they are 
known for their broad excitation spectrum and narrow emission profile enabling efficient 
multiplexing.[3] Based on these features QDs have been promoted as eminent materials for in vivo 
and in vitro biomedical applications such as tumor visualization and intracellular trafficking.[1,4–6] 
With the aim to enhance the biocompatibility and optical properties of the conventional core-shell 
QDs, many QD designs and compositions have been investigated. Recently, gradient alloyed (GA) QDs 
were developed (figure 1).[7] The gradient structure ensures that instead of the usual size-tunable 
emission of conventional QDs, the emission spectra of GA-QDs can be subtly altered by adjusting 
their chemical composition.[8,9] This solves issues related to size limitation sometimes occurring in 
biological labeling and allows multiplexing of QDs without size-related changes in sensitivity.[8,10]  
Despite their excellent properties, the translation of QDs in general toward biomedical applications is 
limited, mainly due to concerns about their toxicity. It is widely established that this toxicity, at least 
in vitro, is mainly attributed to the leaching of toxic cadmium ions and the formation of reactive 
oxygen species (ROS) that can induce secondary toxic effects such as DNA damage and 
apoptosis.[11–15] To avoid these toxic pathways, several groups are attempting to develop a more 
biocompatible QD core by synthesizing e.g. cadmium-free QDs.[16,17] However, next to core 
composition the surface chemistry of the QD can greatly influence toxicity by affecting its cellular 
interactions. 
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Several research groups have recently reported that various types of NMs can modulate 
(macro)autophagy.[18,19] Autophagy is a highly conserved catabolic process essential for 
maintaining cellular homeostasis (figure 2). It is usually present at a basal level in every cell where it 
functions as a cytoplasmic housekeeper for organelle and protein quality control. In addition, 
autophagy serves as a cytoprotective process that is induced to support the cell in stressful 
conditions such as starvation or oxidative stress.[20] Autophagy perturbations have been associated 
with the pathogenesis of multiple diseases including cancer, neurodegeneration and liver 
disease.[21–23] To date, the exact influence of cellular NM exposure on the autophagic process 
remains unclear. Various studies have reported clear induction of autophagy, resulting in cell 
death,[24] whereas others have described an inhibition on autophagosome clearance, which can also 
result in cell death.[25] The direct induction of cell death through the autophagy process however 
remains a topic of debate, as autophagy is mainly a self-preservation process and any alterations 
observed during cell death could simply be the result of secondary unrelated bystander effects of the 
cell trying to recover.[26] In line with the latter view, it has been suggested that the induction of 
autophagy could be beneficial, as the overall toxicity of NMs could be reduced by the protective 
effects of autophagy.[27,28]  
Considering the impact of autophagy induction and inhibition as described above, we believe it is 
critical to characterize the influence of NMs on autophagy from a nanotoxicological point of 
view.[18] However, despite abundant reports on NM-modulated autophagy, only a few studies exist 
related to QDs. Furthermore, very little attention has yet been paid to the potential harm induced by 
the highly promising GA-QDs.[29] In addition, many of those studies are limited to one type of 
coating or lack data on intracellular uptake.[24]  
In this paper we look into the influence of QD surface chemistry on the toxicity and its underlying 
causes by comparing two types of QDs that only differ in their coating. We opted for polyethylene 
glycol (PEG) as a coating, since this is the most commonly applied coating strategy in biomedical 
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applications to reduce unspecific protein binding and prevent aggregation. In addition, PEGylation is 
known to increase the blood circulation time of particles by preventing NP uptake by the 
reticuloendothelial system.[30–32] As a second coating strategy we selected the short ligand 3-
mercaptopropionic acid (MPA) based on previous reports that observed limited toxicity with this 
coating.
29–31
 We therefore wanted to analyze this promising observation further with a special focus 
on autophagy since the influence of MPA coating on this pathway remains unexplored so far.  To this 
end, we examined the aggregation profile, cellular uptake, cytotoxicity and associated ROS levels of 
QDs, and studied their effect on lysosomes and autophagosomes - the two most essential organelles 
of the autophagy pathway.   
3. METHODS 
Materials 
Two types of spherically shaped Gradient Alloy Quantum Dots were purchased from Mesolight LLC 
(Little Rock, Arkansas, USA). Both types have a gradient CdSexS1-x core surrounded by a ZnS shell. 
(Figure 1).  The GA-QDs only differ in their surface coating: one particle is coated with polyethylene 
glycol (PEG) with terminating carboxyl groups while the other one is coated with 3-
mercaptopropionic acid (MPA). Both QDs have an emission maximum at 580nm (Supplementary 
Figure S1), and exhibit very similar quantum yields, i.e. 60% for PEG-QDs and 65% for MPA-QDs. All 
QD dispersions were diluted from the original colloidal suspensions that were stored in H2O with a 
concentration of 10 µM for PEGylated QDs (stored at pH 7) and 15 µM for MPA-coated QDs (stored 
at pH 11). LC3-, p62-, actin and LAMP-1-antibodies were purchased from Cell Signaling (Beverly, 
USA); secondary AlexaFluor® tagged antibodies, LysoTracker®, DQ™ red BSA and CellROX®  were 
purchased from Molecular Probes™ (Invitrogen, Belgium). 
Nanoparticle characterization 
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The hydrodynamic size and zeta potential of the QDs were determined using a Malvern Zetasizer 
Nano (Malvern Instruments, Worcestershire, U.K.). For this purpose the QDs were diluted to a 
concentration of 20 nM in HEPES buffer or Phosphate buffer saline (PBS) prior to performing the  
measurements at 25 °C. The refractive index was set to 2.56 based on the manufacturer’s protocol 
(Mesolight). Size measurements were done in triplicate with three runs per replicate, and presented 
based on the number distribution. The zeta potentials were calculated from the electrophoretic 
mobility based on the Henry equation considering the Smoluchowski approximation. Zeta  potential 
measurements were done in triplicate with two runs per replicate. The stability of both QDs in cell 
culture media was assessed with Single Particle Tracking of which the methodology can be found in 
the Supplementary information.  
Cell culture 
The cervical epithelial cancer cell line HeLa was purchased from ATCC (CCL-2). The stable GFP-LC3 
HeLa cell line was a kind gift from Prof. Felix Randow (MRC Laboratory of Molecular Biology, 
Cambridge, UK). Both cell types were cultured using DMEM/F12 cell culture media (Gibco®, Paisly, 
UK) supplemented with 10% fetal bovine serum (Hyclone®, Cramilton, UK), 1% L-glutamine (Gibco®, 
Paisly, UK) and 2% penicillin – streptomycine solution (Gibco®, Paisly, UK). Cells were passaged at 
80% confluency and incubated at 37°C with 5.0% CO2.  
MTT cell viability 
Cells were seeded in a 96 well plate at a cell density of 20.000 cells per well. After QD treatment the 
medium was removed and the cells were washed twice with PBS (Gibco®, Paisly, UK). Next, fresh 
medium containing 5 mg/ml of MTT reagent (Sigma-Aldrich, USA) was added to the cells and 
incubated for 3 h at 37°C. Following this incubation, the medium was carefully removed and the 
formazan crystals were dissolved by incubation with DMSO on a shaker for 1 h. Finally, the 
absorbance was measured at 590 nm with an Envision plate reader (Perkin Elmer, Zaventem, 
Belgium). The percentage of viability was then calculated by comparison with untreated cells 
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representing 100% viability. To check for potential interference of the QDs with the MTT assay the 
absorbance at 590nm was also measured for several controls. The positive control (cells treated for 
15 min with 0,1% Triton X-100) was compared to cells treated with QDs followed by incubation with 
Triton X-100. Also, culture medium containing QDs and incubated with MTT reagent was compared 
to culture medium only incubated with MTT reagent. In both cases, no significant change in the assay 
readout was detected between the controls. Cellular uptake, oxidative stress, lysosomal and 
autophagy markers were measured by flow cytometry. All autophagy-related studies were 
performed in accordance to the guidelines published by Klionsky et al.[36] 
All flow cytometry experiments were at least performed in triplicate. For this purpose cells were 
seeded in a 24 well plate at a density of 60.000 cells per well. The general protocol was as follows: 
after 24 h of incubating the cells with QDs in full cell culture medium, the medium was removed after 
which a washing step with PBS was performed. Next, the cells were detached with 300 µl of 0.25% 
Trypsin-EDTA (Gibco®, Paisly, UK), followed by neutralizing the trypsin with 500 µl of cell culture 
medium and transferring the cell suspension to FACS tubes. The samples were next centrifuged at 
300g for 5 min, the supernatant was removed, and the cells were resuspended in FACS buffer. This 
wash cycle was performed two times. Finally, the cells were resuspended in 300 µl of FACS buffer 
prior to analyzing them with a FACScalibur flow cytometer (BD, Erembodegem, Belgium). Data 
acquisition was performed with BD CellQuest™ software while the data analysis was done with 
Flowjo software (Tree Star Inc). The staining protocols for the respective experiments are described 
below.  
Cellular uptake. HeLa cells were incubated with 400 µl of medium containing the respective 
concentrations of QDs for 24 h. After this the flow cytometry protocol as described above was 
executed. 
LysoTracker® staining. This dye, which stains all lysosomal vesicles, was used to estimate QD-induced 
changes in total lysosomal content. Cells were exposed to QDs for 24 h, to 50 µM of chloroquine for 
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4h. After a washing step with PBS, cells were incubated with 100 nM of LysoTracker Red® DND-99 for 
30 min at 37°C. 
DQ™ Red BSA staining. This dye, which is degraded by the lysosomal pathway, was used to estimate 
QD-induced changes in the degradative capacity of lysosomes. After a 24 h incubation with QDs and 
a washing step with PBS the cells were treated with 10 µg/ml DQ BSA for 3 h at 37°C, allowing the 
endocytic uptake of the fluorescent BSA. Chloroquine-treated and starved cells were pre-incubated 
for 1 h with 50 µM chloroquine or serum-free medium prior to co-incubation with DQ BSA so that the 
total treatment was each time 4 h.  
CellROX® staining. Cells were exposed to QDs for 24 h. After a washing step with PBS, cells were 
incubated with 5 µM of CellROX® Deep Red for 30 min at 37°C.  
GFP-LC3 detection. This protocol was based on a method described by Eng et al.[37] Hela cells stably 
expressing GFP-LC3 were seeded in a 24 well plate with a density of 60.000 cells per well. The general 
flow cytometry protocol was followed except for the first washing step which was performed with 
0.05% saponin (Sigma-Aldrich, USA) instead of PBS. This special washing step ensures that only the 
LC3 present on autophagosomal membranes, which is insoluble, remains intact. After the saponin 
washing step, two wash cycles with PBS were executed after which the samples were analyzed.  
Immunofluorescence staining for LAMP-1 and LC3 
For these experiments 100.000 cells were seeded in a 35mm microscopy dish, left to adhere 
overnight and were then treated with QDs for 24 h, or with chloroquine or serum-free medium for 4 
h. After a washing step with PBS, the cells were fixed using 2% paraformaldehyde (Sigma-Aldrich, 
USA) for 15 min. Next, the fixative was removed and the cells were washed three times with PBS. The 
cells were next permeabilized by a 15 min incubation with 0.5% Tween 20 (Sigma-Aldrich, USA) in 
PBS. After removing the permeabilization agent the cells were washed three times with blocking 
buffer (5% goat serum in PBS), after which they were incubated with blocking buffer for 15 min.  
Adequately diluted primary rabbit antibodies were then applied to the cells and incubated for 1 h. 
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After washing three times with blocking buffer, the cells were incubated with Goat anti-Rabbit 
Alexafluor® 647 antibodies (Life Technologies, Invitrogen, Belgium) for 1 h. After two final washing 
steps with PBS, the samples were kept in Vectashield antifade medium (Vector Laboratories, USA) at 
4° C until imaging. All the steps of the immunostaining protocol were performed at room 
temperature. The samples were visualized with a Sweptfield Confocal microscope (Nikon, Belgium) 
using a 60x oil Plan Apo objective (Nikon, Belgium). Post-image processing of the images was done 
using ImageJ/FIJI software (NIH).  
Western Blot 
For this experiment 750.000 cells were seeded in a T25 flask. After treatment, the cell medium was 
removed and the cells were washed twice with ice cold PBS and harvested by scraping. The cell 
suspension was then centrifuged for 8 min at 1100 rpm at 4°C. The supernatant was removed and 
the cell pellet was resuspended in RIPA buffer  (Sigma-Aldrich, USA) supplemented with protease 
inhibitors (Sigma-Aldrich, USA). This suspension was next centrifuged at 10 000 g for 10 min at 4°C 
after which the supernatants were collected and kept at -80°C until use. Protein concentrations were 
determined using the DC™ Protein Assay (BD, Erembodegem, Belgium). For Western blotting equal 
amounts of protein were loaded on a 12% SDS-PAGE gel and transferred onto a PVDF membrane 
(BD, Erembodegem, Belgium). After the transfer the blots were blocked with 5% bovine serum 
albumin (Sigma-Aldrich, USA) for 1 h at room temperature after which they were incubated 
overnight at 4°C with the designated primary antibodies diluted in blocking buffer. Next, the blots 
were incubated with HRP-conjugated secondary antibody (Cell Signaling, USA) for 1 h at room 
temperature. Finally the blots were visualized using the Bio-Rad ImmunStar™ WesternC™ 
chemiluminescent kit (Biorad) on a VersaDoc™ Imaging System (Biorad). 
Statistical Analysis 
All experiments were analyzed for statistical significance with a one-way ANOVA followed by the 
Bonferroni post hoc test to estimate significance between treated groups, or followed by the 
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Dunnett post hoc test when compared to an untreated group. The results were considered as 
statistically significant if p < 0.05. All statistical analysis was performed with Graphpad Prism 5 
software (San Diego, CA). 
4. RESULTS 
Quantum Dot characterization  
As described in Figure 3, DLS measurements have shown that both QDs exhibit similar size (∼20 nm) 
and zeta potential (∼ -22 mV) in HEPES buffer. A negative zeta potential could be expected for both 
QDs since MPA is a strong acid and the PEG chains have carboxyl end groups. To characterize the QDs 
in an ion-rich solution (similar to cell medium) we examined their size and zeta potential in PBS. In 
this buffer, the PEGylated QDs remain stable (∼20 nm), however, the MPA-coated ones form 
aggregates (Figure 3A). In PBS the charge of PEGylated QDs is neutralized to -10 mV while MPA-
coated QDs exhibit similar charge as in HEPES buffer, being -22 mV (Figure 3B). As expected, 
exposure to cell culture medium elicited a similar trend  as in PBS: PEGylated QDs show an uniform 
size distribution while MPA-QDs clearly aggregate as indicated by their very broad size distribution. 
(Supplementary Figure S2). 
Uptake and intracellular localization of Quantum Dots  
Uptake experiments (Figure 4) showed that PEGylated QDs are easily taken up at low concentrations, 
though the uptake does reach a plateau around 40 nM and decreases at concentrations above 60 
nM. In contrast, MPA QDs are only efficiently taken up starting from a concentration of 80 nM, and 
their uptake increases proportionally to the administered dose. In order to study the intracellular 
effects later on, we continued our study with dosages of the two types of QDs that should result in 
comparable intracellular concentrations. Considering the similar quantum yield of both QDs we 
compared dosages that gave an identical average fluorescence intensity per cell, i.e. 20 nM PEG QDs 
and 125 nM MPA QDs, as well as 50 nM of PEG QDs and 175 nM of MPA QDs.  
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As discussed in more detail later, Figure 6 shows that both QDs accumulate in the perinuclear region 
and  co-localize strongly with lysosomes, indicating that both particles are taken up by endocytosis.  
Quantum Dot-induced acute toxicity and oxidative stress 
QD-induced cytotoxicity was determined based on reduction in cellular enzymatic activity. This was 
tested using the common MTT viability assay after a QD incubation for 24 h for a concentration range 
up to 200 nM. As shown in Figure 5A, MPA QDs did not evoke significant toxicity over the tested 
concentration range. In contrast, PEGylated QDs clearly elicited a dose dependent toxicity with a 
significant decrease in cell viability ranging from 80.6% (± 1.8) viability at 50 nM to 33.7% (± 1.2) 
viability at 200 nM. Next to enzymatic activity, we also determined cytotoxicity based on cell 
membrane rupture by measuring propidium iodide uptake. Again, exposure to 50 nM of PEGylated 
QDs led to a significant decrease in viability while MPA-QDs induced no cell death up to 175 nM 
(Supplementary Figure S3). The level of ROS, a measure for oxidative stress, was determined by 
incubation of QD treated cells with CellROX®, a dye that becomes fluorescent after oxidation by ROS. 
As shown in Figure 5B, a 24 h exposure of HeLa cells to PEGylated QDs gives rise to significantly 
higher levels of ROS: 123 (±4.3) % for 20 nM and 135 (±4.0)%  for 50 nM. Remarkably, in case of MPA 
QDs the oxidative stress level  decreased, as the ROS levels were significantly reduced to 85 (±4.5)%  
and 76 (± 5.1)%  for 125 nM and 175 nM respectively.  
Impact of Quantum Dots on lysosomal health 
Until recently the lysosome was merely considered as the waste bag of the cell, since it degrades and 
recycles the content delivered to the lysosomal compartment following endocytosis or autophagy. 
However, thanks to recent reports further elucidating its functions the lysosome is now more and 
more perceived as an essential organelle for protecting the cell’s homeostasis.[38] To our interest, its 
activity is also crucial to ensure a functional autophagy pathway (Figure 2). Therefore, we evaluated 
the effect of QDs on lysosomal abundance and functionality by flow cytometry (indicated in Figure 
6). 
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As a first indication, we incubated QD treated cells with LysoTracker, a dye that accumulates in 
lysosomes, and followed its intensity with flow cytometry as a measure for the amount and/or size of 
the lysosomal network.[39] As a positive control we treated the HeLa cells with 50 µM of chloroquine 
for 4h, since it is widely established that this buffer elicits alkalinization of the lysosomal lumen which 
next evokes lysosomal swelling.[40]  As shown in Figure 6A, this treatment indeed led to an almost 
twofold increase (194 ±14%) in LysoTracker intensity. A 24 h incubation with 20 and 50 nM PEGylated 
QDs resulted in an even more substantial increase up to 240 (±15)% and 248 (± 24)% respectively. 
The rise in LysoTracker intensity for the MPA coated QDs was not as spectacular as for their 
PEGylated counterparts though a significant dose-dependent effect was apparent: 125 nM led to 162 
(± 14)%  while 175 nM gave rise to 220 (± 26)%.  
To support this data we performed confocal microscopy on cells stained for LAMP-1, a lysosomal 
membrane marker.[41] As illustrated in Figure 6B some lysosomes of chloroquine-treated cells 
appeared as swollen compared to those of untreated cells, which supports the rise in LysoTracker 
intensity seen with flow cytometry. Instead, confocal images show that the increase in LysoTracker 
intensity in QD-treated cells seems rather due to an increase in the number of lysosomes. Moreover, 
we noticed there was a strong co-localization between lysosomes and both types of QDs, illustrating 
that both QDs were taken up by endocytosis and thus efficiently delivered to the lysosomal 
compartment.  
Finally, we examined the functionality of lysosomes of cells exposed to QDs, i.e. their ability of 
degrading lysosomal content. To this end, HeLa cells were incubated with the Derivatively Quenched 
Bovine Serum Albumin (DQ BSA) dye which consists of BSA proteins that are heavily labeled with 
fluorescent dyes so that a strong quenching effect takes place. Upon (lysosomal) degradation of DQ 
BSA into smaller fragments, this quenching effect is abolished, resulting in a bright fluorescent signal. 
In other words, an increase in fluorescence represents an increase in lysosomal protein degradation.  
As a positive control for increased lysosomal activity, cells were incubated for 4 hours with serum-
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free medium to mimic starvation. Figure 6C demonstrates that this treatment indeed gave rise to a 
substantial increase in DQ BSA fluorescence (176 ±14% ). This in stark contrast to chloroquine-
treated cells where the protein degradation capacity was almost halved (54 ±2.9% ). This is not 
surprising since it has repeatedly been reported that starvation and chloroquine result in 
upregulation of lysosomal activity and lysosomal impairment, respectively.[42,43]  Indeed, the 
alkalinization of lysosomal pH induced by chloroquine inhibits the degradative enzymes that are in 
need of an acidic environment. On the other hand, starvation stimulates lysosomal activity and 
autophagy as the cell attempts to compensate for the nutrient deficit.[44,45]  For the QDs, the effect 
on lysosomal degradation strongly depended on the type of coating. No substantial change in 
degradation was observed upon treatment with PEGylated QDs. MPA QDs, however, did result in 
significant enhancement of DQ BSA fluorescence up to 134 (± 5.4)%  with 175 nM. This signifies that 
MPA-QD uptake results in a starvation-like activation of lysosomal degradative capacity.  
Impact of Quantum Dots on autophagy 
Next, we focused on the most important organelle of the autophagy pathway i.e the 
autophagosome. The most widely investigated marker for autophagosomes is the protein LC3 
(Microtubule Associated Protein 1 Light Chain 3), which is present as two forms within the cell: the 
unactivated form, LC3-I, which is present in the cytosol and the active form LC3-II that is incorporated 
into the autophagosomal membrane (figure 2). Consequently, the autophagy pathway can be 
studied by following the processing of LC3. To reliably interpret changes in autophagy, we inspected 
LC3 by multiple techniques including (i) flow cytometry on HeLa cells stably expressing GFP-LC3 and 
(ii) western blotting on autophagosomal markers. As a first indication the level of GFP-LC3 was 
quantified by flow cytometry in a stably transfected GFP-LC3 HeLa cell line. When autophagosomes 
fuse with lysosomes the GFP will be quenched by the acidic pH.[44,46] The fluorescence intensity 
level of GFP is therefore proportional to the amount of autophagosomes. Furthermore, the saponin 
extraction included in the sample preparation ensures that only the membrane-bound LC3 
contributes to the detected signal.[37] A 4h incubation with 50 µM of chloroquine was applied as a 
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positive control for autophagosome accumulation throughout all autophagy experiments. The 
lysosomal impairment caused by chloroquine leads to a block in autophagosome-lysosome fusion 
which results in the accumulation of large autophagosomes positive for LC3-II (see Figure 2).[44] 
Indeed, as shown in Figure 7A, chloroquine treatment resulted in more than a three-fold increase in 
GFP-LC3 fluorescence intensity compared to untreated cells (342 ±60%). Interestingly, the highest 
concentration of PEGylated QDs gave rise to a significant increase in GFP-LC3 (175 ±26%) while MPA 
QD treatment did not.  
To support this data we performed confocal microscopy on HeLa cells stained for LC3 after treatment 
with PEG QDs , MPA QDs or chloroquine. Here, the confocal images in Figure 7B show that 
chloroquine-treated cells contain some larger autophagosomes compared to untreated cells. In case 
of PEG QD treatment the total autophagosomal content seemed higher. In contrast, MPA QD 
treatment did not appreciably affect autophagosomal abundance nor size. It should be noted that for 
both QDs there was little co-localization with autophagosomes. Since the QDs are not present in the 
cytosol the only way of entering the autophagy pathway would be via fusion of autophagosomes 
with QD-containing lysosomes. Seeing the lack of co-localization we can conclude that these fusion 
events do not take place.  
As mentioned in Figure 2, the level of p62 is often studied to determine if the overall autophagy 
pathway is entirely functional. Since p62 is solely degraded by autophagy, a rise or fall of its protein 
level compared to the untreated condition corresponds with an autophagy blockade or upregulation 
respectively.[47] Figure 7C shows the protein levels of p62 and LC3 as determined by Western 
blotting. Interestingly, the level of p62 was higher for cells treated with 50 nM of PEGylated QDs. As 
expected based on our observations by microscopy and flow cytometry, a higher level of LC3-II was  
spotted upon incubation with PEGylated QDs at 50 nM.  The rise in LC3-II induced by chloroquine was 
even more pronounced. In contrast, no change in both markers was detected upon incubation of 
HeLa cells with MPA-coated QDs.  
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5. Discussion 
In this study we apply a step-by-step approach to carefully examine the toxicity of QDs coated with 
two commonly applied surface ligands. Our data clearly accentuates that the choice of coating is 
crucial for the degree and mechanisms of toxicity induced by QDs on cells: while MPA coated QDs 
were highly biocompatible, PEGylated QDs were severely toxic at higher concentrations. A detailed 
investigation of the ROS production, lysosomal health and autophagy pathway gave some insight in 
the intracellular mechanisms that could account for these observations.  
MPA coated QDs   
Coating of QDs with the short ligand MPA was not sufficient to protect the particles from aggregation 
in buffer or cell culture medium. The aggregated particles were taken up efficiently, though only at 
higher concentrations. This could be expected since it has been observed before that NP 
agglomeration has a negative impact on cellular uptake.[48–50] It is therefore likely that we need a 
higher dosage of MPA-coated QDs to reach similar intracellular fluorescence levels as PEGylated QDs 
because only the smaller NPs of the dispersion of MPA-QDs are able of entering the cells.[51] 
Interestingly, Albanese et al. stated that the effect of particle aggregation on uptake might be cell-
type dependent: gold nanoparticle aggregation led to a reduced uptake in HeLa cells while for a 
melanoma cell type the opposite was true.[49]  In any case, despite the efficient uptake of MPA-QDs, 
they did not inflict any toxicity on HeLa cells.  This biocompatibility corresponds with the findings of 
Nagy et al. who did not detect any cell death in primary human lung cells upon exposure to 
differently sized MPA-coated QDs, though they did not show any uptake data.[34] Soenen et al., 
however, did detect significant toxicity with MPA-coated QDs starting from 50 nM.[29] This 
difference with our data may be attributed to differences in aggregation: their MPA-QDs form 
smaller aggregates, which could lead to more efficient uptake and consequently toxicity at lower 
concentrations. This hypothesis was confirmed in vivo in mice where aggregated MPA-QDs exhibited 
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less toxicity than their unaggregated counterparts.[52] On the other hand, the discrepancy in toxicity 
could also be derived from cell type dependent effects.[53,54]  
The most recognized mechanism of QD-induced toxicity is the production of reactive oxygen species 
(ROS).[55] Shifting ROS levels can indeed lead to a variety of secondary effects such as changes in cell 
signaling and DNA damage.[15] In addition, ROS and oxidative stress are associated with multiple cell 
death pathways and have been identified as important regulators of autophagy.[56–58] Strikingly, 
incubation with MPA-coated QDs led to a significant reduction in ROS levels (Fig. 5B). Though this 
observation was unexpected, an NM-induced reduction in ROS has been reported before.[59] 
Specifically regarding QDs, studies have until now only reported that there is a lack of ROS induction 
by MPA-coated QDs.[34,35]  
Apart from ROS levels, we looked further into the impact of QD exposure on lysosomal health and 
autophagy. As a first step we evaluated the influence of QDs on the number and size of lysosomes. 
Here we found that treatment of HeLa cells with MPA-coated QDs elicited a significant expansion of 
the lysosomal compartment as indicated by the substantially increased levels of LysoTracker. This 
type of enlargement is a commonly reported phenomenon and has been described for various NMs 
including ZnO NPs, fullerenol NPs, polystyrene NPs and QDs.[27,60–62] Interestingly, the increase in 
lysosomal content  was accompanied by a rise in cellular degradation capacity, which is an indication 
for lysosomal activation. A boost in protein degradation was also observed by Chen et al. who, similar 
to our findings, detected an increase in LysoTracker staining and DQ BSA degradation upon 
treatment of human cerebral microvascular endothelial cells with aluminum nanoparticles.[63] In 
addition, Kenzaoui et al. observed lysosomal activation induced in brain-derived endothelial cells by 
multiple NMs such as iron oxide NPs and silica NPs.[64] This kind of lysosomal activation, as caused 
by our MPA-coated QDs, is often accompanied by a similar activation of autophagy.  However, the 
unaltered level of p62 and LC3 indicates that the autophagy pathway is fully functional though at a 
basal level. Similar to autophagy induction, this QD-induced lysosomal activation likely aids the cell in 
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overcoming stress. In combination with the reduced oxidative stress, this could explain the lack of 
toxicity we observed upon exposure of HeLa cells to these QDs. Our findings thus confirm that MPA-
coated QDs are quite biocompatible. Furthermore, our group recently reported that cells labeled 
with GA-QDs can be tracked 1.5 times longer than conventional core-shell QDs.[29] In conclusion, the 
combination of this excellent functionality and biocompatibility makes these MPA-coated GA-QDs 
very well suited for cell labeling applications. 
PEGylated QDs 
Unlike MPA coated QDs, PEGylated QDs do not agglomerate in ion-rich media, most likely due to the 
steric hindrance imparted by the PEG-chains which prevents particle-particle interactions.[65] As 
Pelaz et al. stated, PEGylation more than often leads to a reduction in cellular uptake which is likely 
attributed to the lack of protein adsorption at the particle surface.[66] On the other hand, the 
colloidal stability of our particles likely supports their uptake as stated before by Kirchner et 
al.[51,67] Indeed the smaller and more neutral PEGylated QDs were clearly taken up more efficiently 
(even at lower extracellular concentrations) than the larger negatively charged MPA-coated QDs. 
Starting from 60 nM, however, the uptake of PEGylated QDs shows a downward trend. An 
explanation for this decrease in uptake might be the saturation of surface receptors essential for QD 
uptake, since it has been described before that neutral to negatively charged QDs are actively 
internalized by a variety of saturable endocytosis pathways including clathrin- and caveolae-
mediated endocytosis.[68,69]  Upon investigation of the intracellular location of both QDs we indeed 
found that after 24h they co-localize strongly with LAMP-1 stained lysosomes implying they are taken 
up via endocytosis. The decreased uptake of PEGylated QDs upon treatment with higher 
concentrations could also stem from QD-induced toxicity, as cytotoxicity tests revealed that 
PEGylated QDs were significantly toxic starting from 50 nM. 
Regarding QDs, a common strategy to prevent ROS induction is to limit the dissolution of cadmium 
ions from their core by the application of a surface coating.[51] Clearly, high density PEGylation is not 
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sufficient to prevent ROS production since exposure to 50 nM of PEGylated QDs significantly raised 
the level of ROS in HeLa cells. Since this observation correlates well with the cell death seen at this 
concentration, we suggest this ROS production is at least partly responsible for the observed 
cytotoxicity.  In addition, these findings correspond well with the many reports on QD-induced cell 
death associated with oxidative stress.[12,29,70] However, not only does the coating influence the 
dissolution of ions from the NP core, the coating itself can also exert ROS generation. This was 
observed by Soenen et al. who found that at identical cellular NP levels, PEGylated gold NPs were 
more toxic than non-PEGylated ones, indicating that PEG provokes ROS generation.[67] In any case, 
the difference in toxicity observed between the PEG- and MPA-coated QDs demonstrates that the 
type of surface functionalization can have a marked influence on the toxicity and ROS production of 
QDs. This observation was also made by Nagy et al., who observed less QD-induced toxicity with 
shorter negatively charged surface ligands compared to longer ligands - in our case represented by 
MPA and PEG respectively.[34]  
With regard to the lysosomes, also PEGylated QDs resulted in an enlargement of the lysosomal 
compartment. Interestingly, despite the fact that PEGylated QDs give rise to a more than twofold 
increase in LysoTracker, the degradation of DQ BSA did remain unchanged. We therefore suspect 
that at least a part of these lysosomes exhibit limited or no proteolytic activity and thus these QDs 
lead to lysosomal impairment. Lysosomal impairment is a frequently described mechanism of toxicity 
in cells exposed to various NMs as summarized in a review by Stern et al.[71] The most extensively 
reported mechanism of lysosomal impairment involves lysosome membrane permeabilization. 
However, considering the high LysoTracker dye loading and LAMP-1 staining showing normal 
lysosomal morphology, we believe that in our case the lysosomal membrane is intact. We therefore 
hypothesize that the mechanism underlying this impairment could be lysosomal overload as has 
previously been reported for several particles such as smoke particulates.[71,72] Another mechanism 
that could contribute to the lack of degradation taking place within the lysosomes could be oxidative 
damage inflicted on the lysosomal enzymes by ROS produced during QD lysis.[71] By any means, 
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lysosomal dysfunction is undeniably a toxic parameter worth of investigation since it forms the basis 
of lysosomal storage disorders, a group of degenerative diseases that affect the nervous and 
musculoskeletal systems. In addition, lysosomal malfunction can give rise to an autophagy blockade 
through impaired autophagosome-lysosome fusion, a hypothesis we investigated further.[73] 
When looking into autophagosomal markers, treatment of HeLa cells with 50 nM of PEGylated QDs 
resulted in an elevation of LC3, indicative of an accumulation of autophagosomes. Since the p62 
protein level was also increased, we conclude that  the accumulation of LC3 derives from a reduction 
in autophagosomal turn-over rather than autophagy induction. In other words, the autophagy 
pathway is not fully functional but blocked at its later stage i.e. at autophagosome-lysosome fusion 
(Figure 2). Since no co-localization of QDs with autophagosomes was observed (Figure 7), we 
conclude from this collection of data that PEGylated QDs induce autophagosome accumulation 
through lysosomal impairment.  
This theory is in line with observations made by Ma et al. who detected compromised degradation 
capacity induced by endocytosed AuNPs and consequently defective autophagosome-lysosome 
fusion in normal rat kidney cells.[25] An impaired autophagy flux was also hypothesized by Wang et 
al. who witnessed an increase in the volume of acidic compartments and LC3-II levels upon exposure 
of human brain astrocytoma cells to polystyrene particles.[62] In addition, the same conclusion was 
drawn based on similar observations in kidney cells treated with fullerenol NPs.[61] At first sight our 
findings do seem in contrast with recent observations made by Huang et al who saw that NPs 
modulate autophagy in a dispersity-dependent manner where aggregated NPs induced severe 
autophagic effects while well-dispersed NPs did not.[74] Our study indicates that MPA-QDs, which 
aggregate severely in extracellular medium, do not exert major effects on the autophagy pathway 
while our unaggregated PEGylated QDs clearly do. However, within the cell this phenomenon might 
be the opposite: as stated before it is likely that the large MPA-QD aggregates are not internalized by 
the cell while the smaller PEGylated QDs are taken up very efficiently and likely accumulate, and 
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possibly aggregate, massively inside the endo- and lysosomes. According to Huang et al. this high 
uptake and intracellular accumulation of NPs can next modulate autophagy, which is in line with our 
observations.Since autophagy usually encourages survival, especially in cells undergoing stress, it is 
not surprising that when this function is lost, cytotoxicity becomes inevitable.[75] Our PEGylated QDs 
induce oxidative stress that undoubtedly leads to damaged cytoplasmic material.  Where usually 
autophagy aids in the removal of these materials, this coping mechanism is now absent. The 
autophagy blockade combined with oxidative stress is therefore likely the underlying source of the 
QD-induced cytotoxicity we observed. This disrupted autophagy flux is a serious observation since 
this can lead to the accumulation of protein aggregates and damaged cytoplasmic organelles. This 
buildup of cytoplasmic waste can subsequently provoke genomic instability and tissue degeneration, 
which in turn has a huge impact on physiology.[21] Surely, autophagy dysfunction is linked with the 
onset of many diseases including cancer, neurodegenerative and inflammatory diseases.[21,76] 
However, autophagy perturbation should not be regarded as threatening per se. Actually, in distinct 
cases it can be manipulated to our advantage. Recent reports have stated that inducing autophagy 
malfunction might be an ideal strategy to wipe out (resistant) cancer cells. It seems some types of 
cancer are highly dependent on autophagy for their survival, since autophagy allows them to 
overcome stressors like starvation, hypoxia and even chemotherapy.[18,23] Blocking this 
cytoprotective process would in this case thus lead to their demise. In fact, the anti-cancer activity of 
chloroquine, a chemical we use as a positive control for autophagy blockade, is currently investigated 
in multiple clinical trials.[77] In this regard, the effects induced by PEGylated QDs might allow us to 
combine diagnosis by tumor imaging with anti-cancer therapy. In conclusion, the oxidative stress and 
autophagy blockade caused by these PEGylated GA-QDs has detrimental effects for the cell, 
however, in cases where these effects are desirable like in anti-cancer therapy, these particles could 
be valuable. 
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6. Conclusion 
 
The primary goal of this study was to define the toxicity and its origins of MPA-coated and PEGylated 
QDs with a special emphasis on the autophagy pathway. We observed that despite the fact the two 
studied QDs are completely identical except for their surface coating, their cellular effects induced in 
HeLa cells were remarkably different (Figure 8). This implies that rather than QD composition, the 
surface chemistry primarily defines the functionality and toxicity of the QD. Based on our results we 
conclude that MPA-coated QDs are highly biocompatible, where the lysosomal activation and ROS 
reduction induced by these QDs likely rescues the cell from potentially NM-induced toxic effects. In 
this respect, MPA-coated QDs seem promising candidates for cellular labeling. However, since this 
study is limited by its focus on ROS and autophagy,  future research should involve screening for 
other toxic factors such as DNA damage. As expected, the PEGylated QDs proved to be more 
resistant to aggregation resulting in efficient cell labeling. However, these QDs exhibited significant 
toxicity owing to their capacity to induce ROS production and autophagy malfunction through 
lysosomal impairment. Considering these toxic defects, the PEGylated QDs do not seem suitable for 
biomedical applications except for when autophagy dysfunction is actually desirable e.g. in anti-
cancer therapy. In this regard, it could be valuable to investigate if combination therapy using a 
common chemotherapeutic and this QD might enhance the elimination of therapy-resistant cancer 
cells. Generally, our study highlights the importance of surface chemistry when it comes to 
nanotoxicology as well as the relevance of lysosomal and autophagy dysfunction as a nanomaterial-
induced toxicity mechanism.  
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10.  Figure captions  
 
Figure 1. Schematic design of a core-shell QD (A) and a gradient alloyed QD (B). A core-shell QD 
commonly exists of a metal core enveloped by an inorganic shell and a coating that renders them 
water-soluble and allows for further conjugation.[78] In case of gradient alloyed QDs, the defined 
core-shell interface within the QD is replaced by a gradient composition.  
 
Figure 2. Overview of the mechanistic steps of autophagy and cellular markers investigated in this 
study.  
Autophagy initiates with the synthesis of a phagophore that, while sequestering cytoplasmic cargo, 
elongates and closes to form a double-membraned autophagosome. During the creation of this 
autophagosome cytoplasmic LC3-I is activated by lipidation, forming LC3-II, and incorporated into the 
autophagosomal membrane. The specific targeting of cytoplasmic components for degradation is 
mediated by p62, a protein that links LC3 with the respective materials. Next, the autophagosome 
fuses with a lysosome that supplies the acidic pH and enzymes for degradation of the cargo carried 
by the autophagosome. In the resulting vesicle, the auto(phago)lysosome, the cargo is degraded 
after which the resulting macromolecules are transported into the cytoplasm by permeases. Since 
during this step also the inner membrane of the autolysosome is degraded, the LC3-II within the 
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vesicle is lysed; the LC3-II on the outside is recycled back to LC3-I. The overall process, from 
autophagosome maturation to its degradation is often referred to as autophagy flux.[79] Since the 
buffer chloroquine (CLQ) leads to lysosomal alkalinization we applied it throughout our study to 
mimick lysosomal impairment. Considering this lysosomal impairment causes a block in 
autophagosome-lysosome fusion further down the line, we also used CLQ as a positive control for 
increased autophagosomal abundance due to reduced autophagosomal degradation.[44] As 
lysosomal markers we made use of: LAMP-1, a membrane protein selective for lysosomes;[41] 
LysoTracker, a dye that primarily accumulates in lysosomes; and DQ BSA, a dye that is selectively 
degraded by the lysosomal pathway seeing it enters the cell via endocytosis.[80] 
 
Figure 3. Quantum dot characterization Size (A) and zeta-potential (B) of the QDs in HEPES and PBS. 
Error bars represent the SEM.  
 
Figure 4. Uptake of QDs in HeLa cells. Uptake was determined by flow cytometry after 24h of QD 
exposure in full medium (n=3). The x-axis denotes the QD dosage: for PEGylated QDs this ranges 
from 20 to 100nM, while for MPA-coated QDs this ranges from 80 to 200nM. PEGylated QDs are 
easily taken up at low concentrations though uptake reaches a maximum around 40 nM. MPA-coated 
QDs are taken up proportionally with increasing dosage, though are only taken up efficiently at 
higher concentrations. 20 nM of PEGylated QDs leads to similar intracellular fluorescence levels as 
125 nM of MPA-coated QDs. Similarly, incubation with 50 nM of PEGylated QDs results in similar 
intracellular fluorescence levels as 175 nM of MPA-coated QDs. Error bars represent the SEM.  
Figure 5. Quantum dot induced acute toxicity and oxidative stress. PEGylated QDs induce 
cytotoxicity and oxidative stress, MPA-coated QDs are non-toxic up to 200 nM and reduce oxidative 
stress. (A) relative viability compared to untreated cells (100%) determined by the MTT assay (n=6). 
(B) relative level of CellROX intensity compared to untreated cells (100%) determined by flow 
cytometry (n=6). Error bars represent the SEM.  
 
Figure 6. Impact of Quantum Dots on lysosomal health. PEGylated QDs induce lysosomal 
impairment, while MPA-coated cause lysosomal activation. (A) relative level of LysoTracker intensity 
compared to untreated cells (100%) determined by flow cytometry (n=4). (B) Confocal microscopy on 
LAMP-1 immunostained cells after 24h of exposure to 50 nM PEGylated QDs, 175 nM of MPA-coated 
QDs or 4 h of 50 µM chloroquine (CLQ). N indicates the nucleus, arrows indicate swollen lysosomes. 
Scale bar: 20µm. (C) relative level of DQ BSA intensity compared to untreated cells (100%) 
determined by flow cytometry (n=4). Error bars represent the SEM.  
 
Figure 7. Impact of Quantum Dots on autophagy. PEGylated QDs induce autophagy dysfunction, 
MPA-coated QDs do not influence autophagic markers. (A) relative level of GFP-LC3 intensity 
compared to untreated cells (100%) determined by flow cytometry (n=6). Error bars represent the 
SEM. (B) Confocal microscopy on LC3-immunostained cells after 24h incubation of 50 nM PEGylated 
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QDs, 175 nM of MPA-coated QDs or 4 h of 50 µM chloroquine (CLQ). N indicates the nucleus, arrows 
indicate large autophagosomes. Scale bars: 20µm (C) Western blot on autophagic markers LC3 and 
p62.  
 
Figure 8. Overview of the distinct cellular effects of GA QDs coated with PEG or MPA.  
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Statement of Significance 
Gradient alloyed Quantum Dots (GA-QDs) are highly promising nanomaterials for biomedical imaging 
seeing they exhibit supremely fluorescent properties over conventional QDs. The translation of these 
novel QDs to the clinic requires a detailed toxicological examination, though the data on this is very 
limited. We therefore applied a systematic approach to examine the toxicity of GA-QDs coated with 
two commonly applied surface ligands, this while focusing on the autophagy pathway. The impact of 
QDs on this pathway is of importance since it has been connected with various diseases, including 
cancer. Our data accentuates that the coating defines the impact on autophagy and therefore the 
toxicity induced by QDs on cells: while MPA coated QDs were highly biocompatible, PEGylated QDs 
were toxic. 
